Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 51(4); 2019 > Article
Original Article MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway
Fan Yang, MS1, Hairong Xiong, BS2,3, Li Duan, MS2,3, Qian Li, BS3, Xin Li, BS1, Yongqin Zhou, MD, PhD2,3,4,
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2019;51(4):1420-1429.
DOI: https://doi.org/10.4143/crt.2018.638
Published online: March 4, 2019

1The Second People's Hospital of China Three Gorges University, Yichang, China

2Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China

3Medical College of Three Gorges University, Yichang, China

4The Institute of Infection and Inflammation, China Three Gorges University, Yichang, China

Correspondence: Yongqin Zhou, MD, PhD The Institute of Infection and Inflammation, China Three Gorges University, 8 University Road, Yichang, Hubei Province, 443000, China Tel: 86-7176397438 Fax: 86-7176397328 E-mail: zyjzyq@163.com
*Fan Yang and Hairong Xiong contributed equally to this work.
• Received: November 20, 2018   • Accepted: February 23, 2019

Copyright © 2019 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 11,030 Views
  • 380 Download
  • 73 Web of Science
  • 66 Crossref
  • 76 Scopus
prev next
  • Purpose
    MicroRNAs (miRNAs) are a group of small non-coding RNAs involved in different cancers, including lung cancer. Here, we aim to investigate the expression profiles of circulating miRNAs and their roles contributed to the progress of lung cancer.
  • Materials and Methods
    The levels of circulating miRNA in lung cancer patients were investigated by miRNAs assay. Then we predicted the target genes of aberrantly expressing miRNAs by searching genetic databases. Based on the A549 cells transfected with miR-1246 mimics or miR-1246 inhibitor,we further measured the roles of miR-1246 involving in the epithelial-mesenchymal transition (EMT), migration and invasion capacities of lung cancer cells in vitro. Finally, we detected the effects of miR-1246 on glycogen synthase kinase-3β (GSK-3β)/β-catenin pathway by immunofluorescence and Western blot, respectively.
  • Results
    We identified that 14 miRNAs were aberrantly expressed in the serum of lung cancer patients. Among them, miR-1246 was the most up-regulated. The cell assays indicated that miR-1246 significantly increased the migration and invasion capabilities of A549 lung cancer cells. Meanwhile, immunofluorescence analysis revealed that miR-1246 promoted EMT process of A549 cells accompanying with decreasing E-cadherin expression, while increasing vimentin and transforming growth factor β (TGF-β) expression. Furthermore, an online tool predicated that miR-1246 might bind to 3′-untranslated region of GSK-3β, which was confirmed by overexpression and knockdown of miR-1246 assays.
  • Conclusion
    Taken together, the study illustrates that miR-1246 regulates Wnt/β-catenin pathway through targeting GSK-3β/β-catenin, which partly contributing to tumor metastasis. MiR-1246 may play an essential role in the diagnosis and therapeutic of lung cancer.
Lung cancer is the leading cause of cancer-related death in the world. About 1.8 million people are diagnosed with lung cancer each year, and the 5-year survival rate ranges about 4%-17% depending on stage and regional differences [1-3]. Despite rapid progresses have been made in the field of diagnostic technology and therapeutic methods, most of lung cancer patients are still diagnosed at advanced stages with poor prognosis. To date, there are limited drugs and therapeutic interventions for the majority of patients with lung cancer. Metastasis is the main factor that results in the poor prognosis of lung cancer patients [4,5]. Thus, there is an urgent requirement to identify novel biomarkers for early diagnosis and explore therapeutic strategies that can specifically alleviate tumor burden, especially reduce metastasis, prolong survival of lung cancer patients [5-8].
Epithelial-mesenchymal transition (EMT) is a program of transforming polarized epithelial cells into cells with mesenchymal phenotypes and functions, such as losing the ability of cell-cell adhesion and the phenotypes related to epithelial cells, while increasing mesenchymal cell markers and migratory capacity, resisting to apoptosis, producing extracellular matrix components, etc. [9]. It is well known that EMT plays important roles in a variety of biological processes, for instance, embryonic development, organ formation, wound healing, and fibrosis. Recent studies in cancer have revealed that initiation of metastasis requires invasion, which is enabled by EMT, and loss of E-cadherin is considered to be a fundamental event in EMT [10,11].
MicroRNAs (miRNAs) are a group of small non-coding single-stranded RNAs with approximately 20-23 nucleotides. They are transcribed by RNA polymerase II and then cleaved sequentially by Drosha and Dicer to form miRNA. Through binding to 3' untranslated region (3'-UTR) of target mRNA, miRNAs regulate post-transcriptional expression, accounting for multiple physiological processes like proliferation, differentiation, and apoptosis [1,12].
Recently, studies have demonstrated that the miRNAs were aberrantly expressed in tumor tissue and/or blood of patients with different tumors, including lung cancer[3,13,14]. More efforts have focused on miRNA as a crucial regulator involved in Wnt/β-catenin, Notch and Hedgehog pathway, etc. [15,16]. The Wnt signaling pathway has served as a critical regulator in lung development as well as physiological and pathophysiological processes of adult lung [17,18]. β-Catenin is a key protein in Wnt/β-catenin signaling cascades, and accounts for varying activities, including embryonic development, stem cell maintenance, tumorigenesis, and metastasis. Glycogen synthase kinase-3β (GSK-3β) is a negative regulator of Wnt/β-catenin signaling pathway, which locates in the upstream of β-catenin, and inhibits its excessive activation [19]. Otsuki et al. [11] reported that suppressing GSK-3β could activate Wnt/β-catenin pathway, then promote EMT and metastasis in lung cancer. Together, these data show that aberrant expression of specific miRNAs may act as biomarkers for diagnosis, prediction of prognosis, and promising targeted therapeutic agents in lung cancer patients [14,18]. Although there are increasing studies on miRNAs and lung cancer [2,3,20], to our knowledge, the level of circulating miRNAs in clinical patients with lung cancer, and the mechanism of altered circulating miRNAs on the carcinogenesis of lung cancer have not been well demonstrated.
In the present study, we investigated the expression profile of circulating miRNAs in lung cancer patients, and then explored the roles of remarkably altered miR-1246 involving in malignancy of lung cancer cells.
1. Patients and samples
In this study, we recruited 11 primary lung cancer patients (which composed of 4 squamous carcinomas, 5 adenocarcinomas, and 2 small cell lung cancer cases) and five healthy control individuals (not affected by lung diseases or any neoplastic disorder). The peripheral blood were collected from lung cancer patients prior to therapeutic interventions (surgery resection, chemotherapy, or radiotherapy). The final diagnosis of lung cancer was confirmed by pathological examination of surgical tumor resections.
2. MiRNA assay
MiRNA expression profiles in the serum of lung cancer patients and matched controls were determined by a high-throughput real-time quantitative polymerase chain reaction (RT-qPCR) after we sent the collected sera to Wcgene Biotech Shanghai Company (Shanghai, China). Briefly, total RNAs were isolated from 250 μL serum sample with 750 μL TRIZOL LS Reagent (Invitrogen, Carlsbad, CA) and 1 μL (20 nM) synthesized internal control 1 miRNA to homogenize samples and incubated for 5 minutes at room temperature. Subsequently, 200 μL chloroform were added for separating RNA. The purified RNAs were polyadenylated through a poly(A) polymerase reaction and then reversed-transcribed into cDNA. Individual miRNAs were quantified by qPCR using gene-specific primers (10 μM) for the 36 miRNAs of interest. Detailed step-by-step protocols for RNA isolation, first-strand cDNA synthesis and qPCR are available in the Supplementary Material 1. The miRNA assay analysis was carried out as details described on the website of Wcgene (http://www.wcgene.com).
3. Cell culture and transfection
Non-small cell lung cancer (NSCLC) cell line A549 (lung adenocarcinoma) was obtained from the China Center for Type Culture Collection (CCTCC) (Wuhan, China). Cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS) (Invitrogen), 100 U/mL penicillin, and 50 μg/mL streptomycin in an incubator at 37°C under humidified atmosphere containing 5% CO2. For overexpression of miR-1246 assay, cells were transfected with 100 pmoL of miR-1246 mimics (Gene Pharma, Shanghai, China) or negative control (NC) miRNA using Lipofectamine 2000 (Invitrogen, Thermo Scientific) according to the manufacturer’s protocol. For knockdown assay, cells were transfected with miR-1246 inhibitor or inhibitor negative control (Inh-NC).
4. Cell migration and invasion assays
A549 cells were transfected with miR-1246 mimics or NC, inhibitor, or Inh-NC for 48 hours. In the migration assay, 2×104 cells suspend in 200 μL serum-free medium were added to the upper chamber of a Boyden transwell with 8 μm pores (Costar #3422, Corning Incorporated, Corning, NY). Subsequently, 500 μL medium with 10% FBS was filled into the lower chamber. After incubation for 24 hours at 37°C in a 5% CO2 humidified incubator, cells that did not migrate through the pores and remained on the surface of upper chamber membrane were gently removed by a wet cotton wool. The cells invading the filters were fixed with 4% formaldehyde (Beyotime Biotechnology, Shanghai, China), and then stained with 0.1% crystal violet solution (Beyotime Biotechnology) for 30 minutes. For the invasion assay, the upper chamber of transwell insert was first coated with Matrigel Matrix (BD Biosciences, Franklin Lakes, NJ). Aside from incubating for 48 hours, the other procedures were similar to those in migration assay. Images were captured with light microscope (Olympus, Tokyo, Japan) and cell numbers were counted in five randomly selected fields of each insert.
5. RT-qPCR assay
RT-qPCR assay was applied to evaluate the expression level of mRNA related to the EMT program in A549 cells. Total RNA was isolated from A549 cells with Trizol reagent (Gibco, Rockville, MD), the concentration and purity of isolated RNA were assessed at 260/280 nm by a nanodrop spectrophotometer (ND-2000, Thermo Fisher Scientific, Waltham, MA). For cDNA synthesis, 1 μg RNA was reversely transcribed in a 10 μL reaction mixture, containing 1 μL PrimeScript RT enzyme mix, according to manufacturer’s instructions (TaKaRa, Otsu, Japan). Real-time PCR was conducted in 20 μL reaction system including 1 μL of cDNA, 10 μL SYBR Premix Ex Taq II (TaKaRa), 0.2 μL (10 μM) of both forward and reverse primers. The PCR cycles were as follows: 95°C/30 seconds, 40 cycles of 95°C/5 seconds, 60°C/30 seconds, and the melt-curve analysis was carried out at the end of each experiment to determine that a single product per primer pair was amplified. The amplification and analysis were performed using a StepOne Software v2.1 (ABI, Foster City, CA). All qRT-PCR reactions were run in triplicate and the relative expression levels of specific gene mRNA were calculated by using the comparative threshold method (2−ΔΔCt). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as housekeeping gene. The primer sequences used were as follows: E-cadherin primers, forward 5′-CTGCTCTTGCTGTTTCTTCGG-3′, reverse 5′-AAGTCAAAGTCCTGGTCCTCTTCTC-3′; vimentin primers, forward 5′-CACCTTCGTGAATACCAAGACCTG-3′, reverse 5′-GAAATCCTGCTCTCCTCGCC-3′; transforming growth factor β (TGF-β) primers, forward 5′-CGCCGCCTACTACTGTGAGG-3′, reverse 5′-GATGAA-GTGGACCAGCGTCTG-3′; GAPDH primers, forward 5′-GGTAGTCTCCTAAGACTTCAA-3′, reverse 5′-CCACCCTGTTGCTGTAGCC-3′.
6. Immunofluorescence assay
A549 cells were cultured on the glass cover slips and then transfected as the above stated. After incubation, cells were fixed with 4% formaldehyde for 15 minutes at 4°C, permeabilized with 0.01% Triton X-100 for 5 minutes, and blocked with 1% bovine serum albumin for 30 minutes at room temperature. Then the prepared cells were incubated with the primary antibody GSK-3β (#12456, 1:100, Cell Signaling Technology, Danvers, MA), or β-catenin (#8814, 1:100, Cell Signaling Technology) for 24 hours at 4°C. In the next day, the cells were stained with isotype-specific secondary antibody (Alexa Fluor 594-AffiniPure donkey anti-rabbit IgG) (Jackson ImmunoResearch, West Grove, PA) for 1 hour. DAPI was used to label the nuclei. Following staining, background autofluorescence was quenched by bathing slides in 0.1% Sudan Black B Solution. The slides were mounted using Prolong Gold (Invitrogen). Sections were visualized with a A1R+ confocal microscope (Nikon Corporation, Tokyo, Japan).
7. Western blot assay
Cells were lysed in RIPA buffer with complete protease inhibitor cocktail (Sigma, St. Louis, MO). The protein was quantified using a BCA Protein Assay Kit (Shanghai ExCell Biology, Inc., Shanghai, China). A total of 50 μg protein per sample was subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and then transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA). After blocked in 5% non-fat milk in TBST (pH 7.4) for 1 hour at room temperature, each membrane was incubated with primary antibodies GSK-3β (#12456, 1:1,000, Cell Signaling Technology), β-catenin (#8814, 1:1,000, Cell Signaling Technology), and β-actin (#4970L, 1:5,000, Cell Signaling Technology) overnight at 4°C. Following incubation with the specific secondary antibodies (peroxidase-conjugated AffiniPure goat anti-rabbit lgG, 1:3,000, Wuhan KeRui Biotechnology, Wuhan, China) for 1 hour, chemiluminescence signal was detected using an electrochemiluminescence kit (Cat. G2014-1, Wuhan Servicebio Technology Co., Ltd.). The density of the immunoreactive bands was analyzed using a KODAK MI software system.
8. Statistical analysis
All data derived from at least three independent experiments were presented as mean±standard error of the mean and performed using SPSS ver. 19.0 statistical software (SPSS Inc., Chicago, IL). The p-values were analyzed by one-way ANOVA and Student’s t test. In all analyses, p < 0.05 was considered to be statistically significant.
9. Ethical statement
This study was conducted in compliance with the Declaration of Helsinki. All clinical samples were obtained from consenting individuals according to protocols approved by the Ethics Committee of the Second People's Hospital of China Three Gorges University (No. 2016007).
1. MiR-1246 is up-regulated in the serum of lung cancer patients
MiRNA assay was carried out to identify the expression profiles of miRNA in the serum of lung cancer patients. The results revealed that 10 miRNAs were up-regulated (miRNA-1246, miRNA-376a-5p, miRNA-1299, miRNA-373, miRNA-21, miRNA-140-5p, miRNA-432, miRNA-520d-3p, miRNA-211, and miRNA-132-5p) and four miRNAs were down-regulated (miRNA-302b, miRNA-190b, miRNA-5p, and miRNA-505) in lung cancer patients compared to healthy control subjects (Fig. 1). The whole results of miRNA assay are available in the Supplementary Material 2. Among them, miR-1246 was the most obviously expressing alteration miRNA in the lung cancer patients. Then, we predicted the target genes of these aberrantly expressing miRNAs by searching three different miRNAs databases (http://www.targetscan.org, http://www.microrna.org, http://www.microbase.org). It indicated that these miRNAs were involved in various of biological activities (Table 1), strikingly, most of them were related to metastasis. These data suggested that circulating miRNAs in patients with lung cancer may account for tumor progression, especially for metastasis.
2. MiR-1246 increases the migration and invasion of lung cancer cells
According to the above screening results, we came to focus on activities of the highest expressing miR-1246. The abilities of cell migration and invasion are important aspects of cancer metastasis. Transwell assay is widely used to measure these activities. As shown in our study, miR-1246 mimics treatment obviously increased the migration (the left of Fig. 2A, p < 0.05) and invasion (the left of Fig. 2B, p < 0.05) of lung cancer cells. While miR-1246 inhibitor significantly abrogated these abilities compared to Inh-NC transfected group (the right of Fig. 2A and B). Together the above results demonstrated that miR-1246 promoted metastasis of lung cancer cells by increasing the migration and invasion.
3. MiR-1246 promotes EMT in A549 cells
In order to investigate the effects of miR-1246 on EMT of lung cancer cells, the expression of mRNAs related to EMT process were assessed by qRT-PCR assay. Our data depicted that the level of E-cadherin, as an epithelial marker, was decreased in A549 cells after transfected with miR-1246 mimics, whereas the expression of mesenchymal marker vimentin, and TGF-β both were increased (p < 0.05) (Fig. 3A). Conversely, A549 cells transfected with miR-1246 inhibitor resulted in an increased expression of E-cadherin, while decreased expressions of vimentin and TGF-β (Fig. 3B). Consistently, both overexpression and knockdown experiments revealed that miR-1246 promoted EMT in A549 cells accompanying with the alteration of E-cadherin, Vimentin, and TGF-β protein expression, respectively. Which indicated that miR-1246 could work as a promoter of EMT in lung cancer metastasis in vitro.
4. GSK-3β is a target of miR-1246
MiRNA is well-known to regulate the activities of target genes, accounting for the behaviors of cell. Given the up-regulation of miR-1246 in serum of patients with lung cancer, we then identified the miRNA gene loci to explore the underlying molecular mechanisms of the miR-1246 impacting on malignancy of lung cancer. By using an online target prediction algorithm mirtarbase (http://mirtarbase.mbc.nctu.edu.tw/php/search.php?opt=search_box&kw=miR-1246&sort=id&order=asc&page=2), we predicted the targets of miR-1246. Among the identified potential targets, we chose to focus on the roles of GSK-3β. First, GSK-3β/β-catenin pathway was previously known as regulating tumor progression [2]. Second, the complementary sequence of miR-1246 was found in the 3′-UTR of GSK-3β mRNA (Fig. 4A) (http://mirtarbase.mbc.nctu.edu.tw/php/detail.php?mirtid=MIRT733922), it depicted that miR-1246 could directly target the 3′-UTR of GSK-3β. In order to verify this prediction, we analyzed the roles of miR-1246 on the expression of GSK-3β by immunofluorescence and western blot assay. As shown in Fig. 4B, D, and E, overexpression of miR-1246 significantly decreased GSK-3β expression (the left of Fig. 4B and D), whereas miR-1246 inhibitor increased GSK-3β expression (the right of Fig. 4B and E), which is a negative regulator of Wnt/β-catenin signaling pathway and locates in the upstream of β-catenin. Taken together, our data suggested that miR-1246 could directly target the 3′-UTR of GSK-3β mRNA, the effect may be as an upstream target of β-catenin in regulating cell activities of lung cancer.
5. β-catenin is activated by miR-1246
Previous studies have demonstrated that β-catenin, a crucial component of Wnt/β-catenin signaling pathway, can enter into the nucleus and interact with transcription factors to regulate the expression of target gene [17]. Since Wnt/β-catenin signaling pathway is an important regulator for physiological and pathophysiological processes of adult lung, we evaluated the effect of miR-1246 on the nuclear translocation of β-catenin in A549 cells by overexpression and knockdown assay, respectively. The data from overexpression assay indicated that miR-1246 mimics could strongly elevate the level of β-catenin protein in A549 cells (the left of Fig. 4C and D). Meanwhile, miR-1246 inhibitors significantly reduced the β-catenin protein levels compared to the Inh-NC in the knockdown assay (the right of Fig. 4C and E) (p < 0.05). Therefore, miR-1246 could enhance the level of β-catenin in A549 cell.
Taken together, the above findings indicate that miR-1246 could target GSK-3β/β-catenin to regulate Wnt/β-catenin signaling pathway accounting for the progress of lung cancer cells.
Lung cancer remains the leading cause of cancer lethal worldwide partly for lacking early diagnostic markers, and common metastasis, which is the main cause of lung cancer patients’ death [4]. MiRNAs are secreted by cells into body liquids with stable and constant levels, like in peripheral blood (serum and plasma). Since collecting peripheral blood is more easily and less invasive than obtaining the other types of tissue samples, secreted miRNAs are considered to be potential non-invasive biomarkers for diagnosing and tracking disease progression [12,13,21]. Accumulating evidences indicate that miRNA expression profiles in the serum of patient represents molecular signatures, which is not only accounting for tumorigenesis, but also involving in tumor invasion and metastasis [22,23]. However, there is limited literature concerning the levels of circulating miRNAs and further exploring their roles in the progression of lung cancer. After using a high-through miRNA assay on a small number of serum samples, we found that 14 circulating miRNAs were aberrantly expressed in lung cancer patients. Among them, miR-1246 was the most remarkably altered miRNAs in the serum of lung cancer patients. Similarly, Zhang et al. [24] identified that miR-1246 was enriched in CD166+ lung tumor-initiating cell (TIC, also referred as cancer stem cell [CSC]) from solid tumors relative to CD166– non-TIC in lung cancer patients. Kim et al. [25] discovered that anti-miR-1246 reduced the expressions of stemness-related and EMT-related markers which associated with characteristics of CSCs, such as cellular proliferation, tumorigenesis, colony formation, and invasiveness, etc. in NSCLC cell lines in vitro. Yuan’s group reported that extracellular miR-1246, which was one of different bio-fluids, promoted lung cancer cell proliferation and enhanced radioresistance [26]. Thus, our data imply miR-1246 may be used as a serum biomarker for lung cancer patients.
The EMT process is closely related to initiate the metastasis in many cancer patients [9,10]. Importantly, miRNAs have been shown to regulate EMT [20,25]. Therefore, in this study, we investigated whether miR-1246 alteration accounted for EMT. Here, we found that miR-1246 expression was closely related to the EMT process of lung cancer cells by gaining mesenchymal markers and losing epithelial markers. MiR-1246 could significantly decrease E-cadherin expression and increase vimentin and TGF-β expression, meanwhile, knockdown miR-1246 notably inhibited the EMT. Interestingly, the data from predicting downstream genes of those aberrantly expressed miRNAs also indicated that major of miR-1246’s downstream targets were related to EMT process (Table 1).
It is well known that miRNAs regulate target genes to perform various biological and pathological function [1]. Both GSK-3β and β-catenin are crucial regulators of Wnt/β-catenin signaling implicated in the progress of various tumors [2,17]. Since miR-1246 enhanced lung cancer cell migration and invasion (Fig. 2), we further investigated whether miR-1246 impacted on the expression of GSK-3β and β-catenin during lung cancer cell metastasis. The results derived from overexpression and knockdown assays show that miR-1246 could target the expressions of GSK-3β and β-catenin. These findings are consistent with the prior reports that miR-26a enhanced invasiveness by suppressing GSK-3β in lung cancer and octamer 4/miR-1246 signaling axis promoted Wnt/β-catenin activation in liver CSCs [2,27]. Which indicates that miR-1246 can act as a promoter of lung tumor cells metastasis partly due to down-regulating GSK-3β while up-regulating β-catenin.
Together, we provide strong evidence that miR-1246 may be exploited for the early diagnosis of lung cancer. Moreover, we demonstrated that miR-1246 enhanced EMT activity of A549 cells, a crucial process for metastasis, supporting that miR-1246 can act as a promoter of A549 metastasis. We also dissected the underlying molecular mechanism of miR-1246 involved in regulating Wnt/β-catenin signaling pathway, by directly targeting the expression of GSK-3β and β-catenin, the effect may be partly contributing to the invasion and metastasis of lung cancer. In conclusion, our data illustrated that miR-1246 may behave as a non-invasive biomarker and therapeutic target of lung cancer.
Supplementary materials are available at Cancer Research and Treatment website (https://www.e-crt.org).
Supplementary Material 1
crt-2018-638-suppl1.pdf
Supplementary Material 2
crt-2018-638-suppl2.pdf

Conflict of interest relevant to this article was not reported.

This work was supported by Natural Science Foundation of Hubei Province (2017CFB573), Scientific Research and Development Projects of Yichang Municipality (A16-301-29, A17-301-24) and Open Foundation of Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy (Three Gorges University) (2015KZL-13, 2018KZL06).
Fig. 1.
Expression profiling of circulating miRNAs in patients with lung cancer. (A) MiRNA assay analysis of circulating miRNAs from the patients with lung cancer was presented in a heat map (11 lung cancer vs. 5 health control; the 11 lung cancer group includes 4 squamous carcinomas, 4 adenocarcinomas, and 2 small cell lung cancer cases). (B) The 14 miRNAs were differentially expressed in 11 lung cancer vs. 5 health control (p < 0.05, fold-change > 2 or < 0.5). A differentially expressed miRNA was considered if their expression levels showed with fold-changes greater than 2.0 or less than 0.5. Red and blue colors indicate increased and decreased expression, respectively.
crt-2018-638f1.jpg
Fig. 2.
MiR-1246 enhances the migration and invasion of A549 cells. Migration and invasion assays were performed after A549 transfected with miR-1246 mimics or negative control (NC) miRNA, miR-1246 inhibitor or inhibitor negative control (Inh-NC) for 48 hours. The cells that migrated and invasive were counted, the representative images were shown. Scale bar=100 μm. (A) The migration ability of A549 cells. (B) The invasion capacity of A549 cells. Experiments were performed at least in triplicate and data are represented as mean±standard error of mean (*p < 0.05).
crt-2018-638f2.jpg
Fig. 3.
MiR-1246 promotes epithelial-mesenchymal transition (EMT) in A549 cells. The mRNA expression of markers (E-cadherin, vimentin, and transforming growth factor β [TGF-β]) related to EMT were measured by real-time quantitative polymerase chain reaction (RT-qPCR) assay. A549 cells were transfected with miR-1246 mimics or negative control (NC), miR-1246 inhibitor, or inhibitor negative control (Inh-NC). After 48 hours, whole cell lysates were prepared and RT-qPCR assay determined the mRNA level of EMT-related markers. (A) The mRNA levels of E-cadherin, vimentin, and TGF-β in A549 cells transfected by miR-1246 mimics or NC. (B) The levels of E-cadherin, vimentin, and TGF-β mRNA in A549 cells transfected with miR-1246 inhibitor or Inh-NC. All experiments were carried out more than three times and results are expressed as mean±standard error of mean (*p < 0.05, **p < 0.01).
crt-2018-638f3.jpg
Fig. 4.
MiR-1246 regulates Wnt/β-catenin signaling pathway through targeting glycogen synthase kinase-3β (GSK-3β)/β-catenin. (A) GSK-3β was identified as a putative target of miR-1246 through prediction databases for bioinformatics search. Schematics showing the predicted binding site of miR-1246 in the 3' untranslated region of GSK-3β. (B-E) The protein levels of GSK-3β (B, D, E) and β-catenin (C, D, E) from A549 cells transfected with miR-1246 mimics or negative control (NC), miR-1246 inhibitor, or inhibitor negative control (Inh-NC) were determined by immunofluorescence and western blot assay, respectively. All the values are shown as mean±standard error of mean and pooled from three independent experiments (*p < 0.05).
crt-2018-638f4.jpg
Table 1.
The enriched FunRich pathway of predicted genes
Pathway Gene (%) p-value lg(p-value)
CDC42 signaling events 13.547 0.007 2.145
TGF-β receptor signaling 5.843 0.009 2.029
TNF receptor signaling pathway 5.688 0.013 1.889
p53 pathway 3.619 0.036 1.447
Epithelial-to-mesenchymal transition 3.464 0.061 1.212
Canonical Wnt signaling pathway 3.309 0.003 2.503
C-Myc pathway 2.947 0.029 1.537
Regulation of nuclear β-catenin signaling 2.689 0.032 1.501

TGF-β, transforming growth factor β; TNF, tumor necrosis factor.

  • 1. Uddin A, Chakraborty S. Role of miRNAs in lung cancer. J Cell Physiol. 2018;Apr. 20[Epub]. https://doi.org/10.1002/jcp.26607Article
  • 2. Lin G, Liu B, Meng Z, Liu Y, Li X, Wu X, et al. MiR-26a enhances invasive capacity by suppressing GSK3beta in human lung cancer cells. Exp Cell Res. 2017;352:364–74. ArticlePubMed
  • 3. Jiang W, Wei K, Pan C, Li H, Cao J, Han X, et al. MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer. Cell Prolif. 2018;51:e12502ArticlePubMedPMC
  • 4. Wu KL, Tsai MJ, Yang CJ, Chang WA, Hung JY, Yen CJ, et al. Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib. Lung Cancer. 2015;88:187–94. ArticlePubMed
  • 5. Reck M, Popat S, Reinmuth N, De Ruysscher D, Kerr KM, Peters S, et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl 3:iii27–39. ArticlePubMedPDF
  • 6. Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I. Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci. 2018;75:3539–51. ArticlePubMedPMCPDF
  • 7. Song L, Peng L, Hua S, Li X, Ma L, Jie J, et al. miR-144-5p enhances the radiosensitivity of non-small-cell lung cancer cells via targeting ATF2. Biomed Res Int. 2018;2018:5109497.ArticlePubMedPMCPDF
  • 8. Kim S, Kim TM, Kim DW, Kim S, Kim M, Ahn YO, et al. Acquired resistance of MET-amplified non-small cell lung cancer cells to the MET inhibitor capmatinib. Cancer Res Treat. 2019;51:951–62. ArticlePubMedPDF
  • 9. Nowrin K, Sohal SS, Peterson G, Patel R, Walters EH. Epithelial-mesenchymal transition as a fundamental underlying pathogenic process in COPD airways: fibrosis, remodeling and cancer. Expert Rev Respir Med. 2014;8:547–59. ArticlePubMed
  • 10. Sung WJ, Kim H, Park KK. The biological role of epithelial-mesenchymal transition in lung cancer (Review). Oncol Rep. 2016;36:1199–206. ArticlePubMed
  • 11. Otsuki Y, Saya H, Arima Y. Prospects for new lung cancer treatments that target EMT signaling. Dev Dyn. 2018;247:462–72. ArticlePubMed
  • 12. Martinez-Rivera V, Negrete-Garcia MC, Avila-Moreno F, Ortiz-Quintero B. Secreted and tissue miRNAs as diagnosis biomarkers of malignant pleural mesothelioma. Int J Mol Sci. 2018;19:E195.Article
  • 13. Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, et al. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 2018;9:15350–64. ArticlePubMedPMC
  • 14. Li L, Sun Y, Feng M, Wang L, Liu J. Clinical significance of blood-based miRNAs as biomarkers of non-small cell lung cancer. Oncol Lett. 2018;15:8915–25. ArticlePubMedPMC
  • 15. Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W, et al. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/beta-catenin signaling in non-small-cell lung cancer. Mol Carcinog. 2018;57:842–53. ArticlePubMed
  • 16. Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. Int J Cancer. 2010;126:1283–90. ArticlePubMedPMC
  • 17. Skronska-Wasek W, Gosens R, Konigshoff M, Baarsma HA. WNT receptor signalling in lung physiology and pathology. Pharmacol Ther. 2018;187:150–66. ArticlePubMed
  • 18. Tanaka K, Kumano K, Ueno H. Intracellular signals of lung cancer cells as possible therapeutic targets. Cancer Sci. 2015;106:489–96. ArticlePubMedPMC
  • 19. Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50–60. ArticlePubMed
  • 20. Jia Z, Zhang Y, Xu Q, Guo W, Guo A. miR-126 suppresses epithelial-to-mesenchymal transition and metastasis by targeting PI3K/AKT/Snail signaling of lung cancer cells. Oncol Lett. 2018;15:7369–75. ArticlePubMedPMC
  • 21. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–8. ArticlePubMedPMC
  • 22. Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, et al. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. Mol Oncol. 2014;8:874–83. ArticlePubMedPMC
  • 23. Ortiz-Quintero B. Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Prolif. 2016;49:281–303. ArticlePubMedPMC
  • 24. Zhang WC, Chin TM, Yang H, Nga ME, Lunny DP, Lim EK, et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702.ArticlePubMedPMCPDF
  • 25. Kim G, An HJ, Lee MJ, Song JY, Jeong JY, Lee JH, et al. HsamiR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. Lung Cancer. 2016;91:15–22. ArticlePubMed
  • 26. Yuan D, Xu J, Wang J, Pan Y, Fu J, Bai Y, et al. Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5. Oncotarget. 2016;7:32707–22. ArticlePubMedPMC
  • 27. Chai S, Ng KY, Tong M, Lau EY, Lee TK, Chan KW, et al. Octamer 4/microRNA-1246 signaling axis drives Wnt/beta-catenin activation in liver cancer stem cells. Hepatology. 2016;64:2062–76. ArticlePubMed

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Apoptotic extracellular vesicles derived from hypoxia-preconditioned mesenchymal stem cells within a modified gelatine hydrogel promote osteochondral regeneration by enhancing stem cell activity and regulating immunity
      Zhengang Ding, Zineng Yan, Xun Yuan, Guangzhao Tian, Jiang Wu, Liwei Fu, Han Yin, Songlin He, Chao Ning, Yazhe Zheng, Zhichao Zhang, Xiang Sui, Libo Hao, Yuting Niu, Shuyun Liu, Weimin Guo, Quanyi Guo
      Journal of Nanobiotechnology.2024;[Epub]     CrossRef
    • Small Extracellular Vesicles Derived from Helicobacter Pylori‐Infected Gastric Cancer Cells Induce Lymphangiogenesis and Lymphatic Remodeling via Transfer of miR‐1246
      Chen Lu, Li Xie, Shengkui Qiu, Tianlu Jiang, Luyao Wang, Zetian Chen, Yiwen Xia, Jialun Lv, Ying Li, Bowen Li, Chao Gu, Zekuan Xu
      Small.2024;[Epub]     CrossRef
    • Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
      Maliheh Entezari, Mahshid Deldar Abad Paskeh, Sima Orouei, Amirabbas Kakavand, Shamin Rezaei, Elahe Sadat Hejazi, Parya Pashootan, Naghmeh Nazdari, Alireza Tavakolpournegari, Mehrdad Hashemi, Shokooh Salimimoghadam, Sepideh Mirzaei, Afshin Taheriazam, Sae
      Current Cancer Drug Targets.2024; 24(1): 94.     CrossRef
    • Exosomal derived miR-1246 from hydroquinone-transformed cells drives S phase accumulation arrest by targeting cyclin G2 in TK6 cells
      Yuting Chen, Lin Chen, Shiheng Zhu, Hui Yang, Zhongming Ye, Huanhuan Wang, Haipeng Wu, Yao Wu, Qian Sun, Xiaoshan Liu, Hairong Liang, Huanwen Tang
      Chemico-Biological Interactions.2024; 387: 110809.     CrossRef
    • Role of adhesion molecules in cancer and targeted therapy
      Chunmei Fan, Fang Xiong, Shanshan Zhang, Zhaojian Gong, Qianjin Liao, Guiyuan Li, Can Guo, Wei Xiong, He Huang, Zhaoyang Zeng
      Science China Life Sciences.2024; 67(5): 940.     CrossRef
    • Wnt/β-catenin-driven EMT regulation in human cancers
      Wenhua Xue, Lin Yang, Chengxin Chen, Milad Ashrafizadeh, Yu Tian, Ranran Sun
      Cellular and Molecular Life Sciences.2024;[Epub]     CrossRef
    • miR‐1246 promotes osteosarcoma cell migration via NamiRNA‐enhancer network dependent on Argonaute 2
      Shuai Yang, Qingping Zou, Ying Liang, Dapeng Zhang, Lina Peng, Wei Li, Wenxuan Li, Mengxing Liu, Ying Tong, Lu Chen, Peng Xu, Zhicong Yang, Kaicheng Zhou, Jianru Xiao, Hailin Wang, Wenqiang Yu
      MedComm.2024;[Epub]     CrossRef
    • miR-1246-overexpressing exosomes improve UVB-induced photoaging by activating autophagy via suppressing GSK3β
      Wei Gao, Limin Yuan, Yue Zhang, Fangzhou Huang, Chen Ai, Tianci Lv, Jiale Chen, Hui Wang, Yixin Ling, Yu-shuai Wang
      Photochemical & Photobiological Sciences.2024; 23(5): 957.     CrossRef
    • Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer
      Caiyan Yin, Jianwei Yu, Gaohua Liu, Jun He, Peng Wu
      Pathology - Research and Practice.2024; 257: 155315.     CrossRef
    • Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma
      Farah Ramadan, Raya Saab, Farah Ghamloush, Rita Khoueiry, Zdenko Herceg, Ludovic Gomez, Bassam Badran, Philippe Clezardin, Nader Hussein, Pascale A. Cohen, Sandra E. Ghayad
      Cancers.2024; 16(9): 1652.     CrossRef
    • Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer
      Zixu Zhang, David Westover, Zhantong Tang, Yue Liu, Jinghan Sun, Yunxi Sun, Runqing Zhang, Xingyue Wang, Shihui Zhou, Nigaerayi Hesilaiti, Qi Xia, Zhenfang Du
      Journal of Translational Medicine.2024;[Epub]     CrossRef
    • A study of microRNAs as new prognostic biomarkers in anal cancer patients
      Olav Dahl, Mette Pernille Myklebust
      Acta Oncologica.2024; 63: 456.     CrossRef
    • Extracellular vesicles from highly invasive melanoma subpopulations increase the invasive capacity of less invasive melanoma cells through mir-1246-mediated inhibition of CCNG2
      Tim Kingreen, Stefanie Kewitz-Hempel, Christian Rohde, Gerd Hause, Cord Sunderkötter, Dennis Gerloff
      Cell Communication and Signaling.2024;[Epub]     CrossRef
    • Identification of common salivary miRNA in oral lichen planus and oral squamous cell carcinoma: systematic review and meta-analysis
      Maryam Koopaie, Parisa Akhbari, Mahnaz Fatahzadeh, Sajad Kolahdooz
      BMC Oral Health.2024;[Epub]     CrossRef
    • Exosomal microRNAs in cancer metastasis: A bridge between tumor micro and macroenvironment
      Mohamed J. Saadh, Amirmohammad Khalifehsoltani, Abbas Hameed Abdul Hussein, Omer Qutaiba B. Allela, Hayder Naji Sameer, Jasur Rizaev, Huda Ghassan Hameed, Ameer Hassan Idan, Fahad Alsaikhan
      Pathology - Research and Practice.2024; 263: 155666.     CrossRef
    • Research progress of lncRNA and miRNA in hepatic ischemia-reperfusion injury
      Shan-Fei Zhu, Wei Yuan, Yong-Liang Du, Bai-Lin Wang
      Hepatobiliary & Pancreatic Diseases International.2023; 22(1): 45.     CrossRef
    • MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
      Si-si Qi, Ying Miao, You-yu Sheng, Rui-ming Hu, Jun Zhao, Qin-ping Yang
      Annals of Dermatology.2023; 35(1): 46.     CrossRef
    • Prolonged exposure to the herbicide atrazine promotes kidney fibrosis by activating Wnt/β‐catenin signaling in rats
      Taiwei Wang, Xuemiao Huang, Jian Liu, Wei Liu, Zhaoyun Yang, Kang He, Junyu Chen, Lijing Zhao
      Environmental Toxicology.2023; 38(5): 1143.     CrossRef
    • MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation
      Elizabeth Proaño-Pérez, Laia Ollé, Yanru Guo, Cristina Aparicio, Mario Guerrero, Rosa Muñoz-Cano, Margarita Martin
      International Journal of Molecular Sciences.2023; 24(4): 3515.     CrossRef
    • The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/β-catenin pathway
      Yuwei Zhang, Haili Zhou, Caifei Ding
      Gynecological Endocrinology.2023;[Epub]     CrossRef
    • The role of selected non-coding RNAs in the biology of non-small cell lung cancer
      Kajetan Kiełbowski, Konrad Ptaszyński, Janusz Wójcik, Małgorzata Edyta Wojtyś
      Advances in Medical Sciences.2023; 68(1): 121.     CrossRef
    • Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
      Afshin Taheriazam, Seyedeh Delaram Bayanzadeh, Melika Heydari Farahani, Sarah Mojtabavi, Mohammad Arad Zandieh, Sadaf Gholami, Mohammad Hossein Heydargoy, Maryam Jamali Hondori, Zahra Kangarloo, Mitra Behroozaghdam, Ramin Khorrami, Mohammad Ali Sheikh Bei
      European Journal of Pharmacology.2023; 951: 175781.     CrossRef
    • Isolation, Characterization, and Anti-Idiopathic Pulmonary Fibrosis Activity of a Fucoidan from Costaria costata
      Sijie Wei, Lihua Geng, Haoyu Yu, Jing Wang, Yang Yue, Quanbin Zhang, Ning Wu
      Molecules.2023; 28(11): 4343.     CrossRef
    • Novel shikonin derivative suppresses tumor growth and metastasis intervention of Wnt/β-catenin pathway
      Hongwei Han, Zhongling Wen, Xiaohui Lai, Minkai Yang, Jiangyan Fu, Liangjie Yang, Qingqing Chen, Yudi Ma, Wencai Jie, Changyi Wang, Tongming Yin, Guihua Lu, Xiaoming Wang, Shucun Sun, Quan Zhao, Jinliang Qi, Hongyan Lin, Yonghua Yang
      Process Biochemistry.2023; 132: 297.     CrossRef
    • miR-4739 promotes epithelial-mesenchymal transition and angiogenesis in “driver gene-negative” non-small cell lung cancer via activating the Wnt/β-catenin signaling
      Wenjian Cen, Qin Yan, Wenpeng Zhou, Minjie Mao, Qitao Huang, Yaobin Lin, Neng Jiang
      Cellular Oncology.2023; 46(6): 1821.     CrossRef
    • Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
      Elizabeth Córdoba-Lanús, Angélica Domínguez de-Barros, Alexis Oliva, Delia Mayato, Francisca Gonzalvo, Ana Remírez-Sanz, Javier J. Zulueta, Bartolomé Celli, Ciro Casanova
      International Journal of Molecular Sciences.2023; 24(15): 12437.     CrossRef
    • MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives
      Federico Pettorossi, Michela Gasparotto, Anna Ghirardello, Chiara Franco, Giulio Ceolotto, Alessandra Giannella, Luca Iaccarino, Elisabetta Zanatta, Andrea Doria, Mariele Gatto
      Current Opinion in Rheumatology.2023; 35(6): 374.     CrossRef
    • Current landscape of miRNAs and TGF‐β signaling in lung cancer progression and therapeutic targets
      Bashdar Mahmud Hussen, Safeen Jasim Saleem, Snur Rasool Abdullah, Sayran Mohamadtahr, Hazha Jamal Hidayat, Mohammed Fatih Rasul, Mohammad Taheri, Arda Kiani
      Molecular and Cellular Probes.2023; 72: 101929.     CrossRef
    • miR‐199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1
      Sheng Hu, Qiang Zhou, Qiang Lu, Xi Guo, Yong Wang, Yi‐Xing Duan
      The Kaohsiung Journal of Medical Sciences.2023; 39(12): 1178.     CrossRef
    • A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
      Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, Waleed Hassan Almalki, Sami I. Alzarea, Imran Kazmi, Shakir Saleem, Ruqaiyah Khan, Najla Altwaijry, Harish Dureja, Sachin Kumar Singh, Kamal Dua
      International Journal of Biological Macromolecules.2023; 253: 127375.     CrossRef
    • Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer
      Jennifer Sally Samson, Venkatachalam Deepa Parvathi
      Medical Oncology.2023;[Epub]     CrossRef
    • Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer
      Magdalena Niemira, Anna Erol, Agnieszka Bielska, Anna Zeller, Anna Skwarska, Karolina Chwialkowska, Mariusz Kuzmicki, Jacek Szamatowicz, Joanna Reszec, Pawel Knapp, Marcin Moniuszko, Adam Kretowski
      Scientific Reports.2023;[Epub]     CrossRef
    • MiR-1246 regulates the PI3K/AKT signaling pathway by targeting PIK3AP1 and inhibits thyroid cancer cell proliferation and tumor growth
      Jingyan Li, Zhanlei Zhang, Jieting Hu, Xiaoting Wan, Wei Huang, Hong Zhang, Ningyi Jiang
      Molecular and Cellular Biochemistry.2022; 477(3): 649.     CrossRef
    • A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers
      Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri, Mohammad Samadian
      Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
    • The roles of G3BP1 in human diseases (review)
      Yidong Ge, Jiabei Jin, Jinyun Li, Meng Ye, Xiaofeng Jin
      Gene.2022; 821: 146294.     CrossRef
    • miRNome Profiling and Functional Analysis Reveal Involvement of hsa-miR-1246 in Colon Adenoma-Carcinoma Transition by Targeting AXIN2 and CFTR
      Rokas Lukosevicius, Simonas Juzenas, Violeta Salteniene, Ugne Kulokiene, Justina Arstikyte, Georg Hemmrich-Stanisak, Andre Franke, Alexander Link, Paulius Ruzgys, Saulius Satkauskas, Henrikas Pauzas, Tadas Latkauskas, Gediminas Kiudelis, Francesc Balaguer
      International Journal of Molecular Sciences.2022; 23(4): 2107.     CrossRef
    • Identification of circ_0000375 and circ_0011536 as novel diagnostic biomarkers of colorectal cancer
      Teng-Fei Yin, Shi-Yu Du, Dong-Yan Zhao, Xi-Zhen Sun, Yuan-Chen Zhou, Qian-Qian Wang, Ge-Yu-Jia Zhou, Shu-Kun Yao
      World Journal of Clinical Cases.2022; 10(11): 3352.     CrossRef
    • Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases
      Sherona R. Sirkisoon, Grace L. Wong, Noah R. Aguayo, Daniel L. Doheny, Dongqin Zhu, Angelina T. Regua, Austin Arrigo, Sara G. Manore, Calvin Wagner, Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui-Wen Lo
      Cancer Letters.2022; 540: 215726.     CrossRef
    • MiR‐1246 is responsible for lung cancer cells‐derived exosomes‐mediated promoting effects on lung cancer stemness via targeting TRIM17
      Zhengcheng Liu, Wei Zhao, Rusong Yang
      Environmental Toxicology.2022; 37(11): 2651.     CrossRef
    • APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b
      Giulia Antoniali, Emiliano Dalla, Giovanna Mangiapane, Xiaolong Zhao, Xinming Jing, Yi Cheng, Veronica De Sanctis, Dilara Ayyildiz, Silvano Piazza, Mengxia Li, Gianluca Tell
      Cellular and Molecular Life Sciences.2022;[Epub]     CrossRef
    • miR-1246 Promotes Laryngeal Squamous Cell Carcinoma Progression by Interacting with THBS1
      Lifeng Wu, Na Zuo, Shuo Pan, Yue Wang, Qixue Wang, Jun Ma
      Journal of Environmental Pathology, Toxicology and Oncology.2022; 41(3): 65.     CrossRef
    • Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β
      Shuo Wang, Peng Du, Yudong Cao, Jinchao Ma, Xiao Yang, Ziyi Yu, Yong Yang
      Cell Death Discovery.2022;[Epub]     CrossRef
    • Discovery and validation of circulating miRNAs for the clinical prognosis of severe dengue
      Umaporn Limothai, Nattawat Jantarangsi, Natthasit Suphavejkornkij, Sasipha Tachaboon, Janejira Dinhuzen, Watchadaporn Chaisuriyong, Supachoke Trongkamolchai, Mananya Wanpaisitkul, Chatchai Chulapornsiri, Anongrat Tiawilai, Thawat Tiawilai, Terapong Tantaw
      PLOS Neglected Tropical Diseases.2022; 16(10): e0010836.     CrossRef
    • miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
      Hang Yan, Shengjie Tang, Shoujun Tang, Jun Zhang, Haiyang Guo, Chao Qin, Haiyang Hu, Chuan Zhong, Li Yang, Yunhe Zhu, Haining Zhou
      Frontiers in Pharmacology.2022;[Epub]     CrossRef
    • Application of bioactive metal ions in the treatment of bone defects
      Shaorong Li, Yutao Cui, He Liu, Yuhang Tian, Gan Wang, Yi Fan, Jingwei Wang, Dankai Wu, Yanbing Wang
      Journal of Materials Chemistry B.2022; 10(45): 9369.     CrossRef
    • ExoBCD: a comprehensive database for exosomal biomarker discovery in breast cancer
      Xuanyi Wang, Zixuan Chai, Guizhi Pan, Youjin Hao, Bo Li, Ting Ye, Yinghong Li, Fei Long, Lixin Xia, Mingwei Liu
      Briefings in Bioinformatics.2021;[Epub]     CrossRef
    • MicroRNAs and Lung Cancer: A Review Focused on Targeted Genes
      Yao-Hui Wang, Zhi-Ruo Zhu, De Tong, Rui Zhou, Kui Xiao, Ling Peng
      Exploratory Research and Hypothesis in Medicine.2021; 000(000): 1.     CrossRef
    • Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion
      Mingyu Qian, Zihang Chen, Xiaofan Guo, Shaobo Wang, Zongpu Zhang, Wei Qiu, Yanhua Qi, Shouji Zhang, Jianye Xu, Rongrong Zhao, Hao Xue, Gang Li
      Laboratory Investigation.2021; 101(5): 612.     CrossRef
    • MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
      Shengjie Tang, Shuangjiang Li, Tao Liu, Yiwei He, Haiyang Hu, Yunhe Zhu, Shoujun Tang, Haining Zhou
      Cancer Letters.2021; 502: 71.     CrossRef
    • CD9 Upregulation-Decreased CCL21 Secretion in Mesenchymal Stem Cells Reduces Cancer Cell Migration
      Chia-Chu Hsieh, Szu-Chun Hsu, Ming Yao, Dong-Ming Huang
      International Journal of Molecular Sciences.2021; 22(4): 1738.     CrossRef
    • Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients
      Eijiro Ueta, Koichiro Tsutsumi, Hironari Kato, Hiroshi Matsushita, Hidenori Shiraha, Masakuni Fujii, Kazuyuki Matsumoto, Shigeru Horiguchi, Hiroyuki Okada
      Scientific Reports.2021;[Epub]     CrossRef
    • Day 7 Embryos Change the Proteomics and Exosomal Micro-RNAs Content of Bovine Uterine Fluid: Involvement of Innate Immune Functions
      Kazuya Kusama, Mohammad B. Rashid, Rasoul Kowsar, Mohamed A. Marey, Anup K. Talukder, Kentaro Nagaoka, Masayuki Shimada, Hasan Khatib, Kazuhiko Imakawa, Akio Miyamoto
      Frontiers in Genetics.2021;[Epub]     CrossRef
    • MiRNAs and Cancer: Key Link in Diagnosis and Therapy
      Yu Shi, Zihao Liu, Qun Lin, Qing Luo, Yinghuan Cen, Juanmei Li, Xiaolin Fang, Chang Gong
      Genes.2021; 12(8): 1289.     CrossRef
    • Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway
      Fengfeng Sun, Peng Sun, Xiaofeng Yang, Liangliang Hu, Jianguo Gao, Tao Tian
      Aging.2021; 13(18): 22528.     CrossRef
    • Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer
      Xuyang Liang, Zhimei Zhang, Lu Wang, Shuxian Zhang, Ling Ren, Shouying Li, Jing Xu, Shengxiang Lv
      Bioengineered.2021; 12(2): 10023.     CrossRef
    • MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
      Yue-chu Dai, Yin Pan, Ming-ming Quan, Qi Chen, Yue Pan, Yan-yun Ruan, Jian-guo Sun
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Silencing of miR-1246 Induces Cell Cycle Arrest and Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells by Promoting ZNF23 Transcription
      Lu Cai, Qian Zhang, Lili Du, Feiyun Zheng
      Cytogenetic and Genome Research.2021; 161(10-11): 488.     CrossRef
    • Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo
      Petro Zhupanyn, Alexander Ewe, Thomas Büch, Anastasia Malek, Phil Rademacher, Claudia Müller, Anja Reinert, Yarúa Jaimes, Achim Aigner
      Journal of Controlled Release.2020; 319: 63.     CrossRef
    • MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer
      Xing-Ning Lai, Jun Li, Li-Bo Tang, Wen-Tong Chen, Lei Zhang, Li-Xia Xiong
      International Journal of Molecular Sciences.2020; 21(4): 1193.     CrossRef
    • Maimendong and Qianjinweijing Tang (Jin formula) suppresses lung cancer by regulation of miR-149-3p
      Zequn Jiang, Yanxia Ma, Tian Tian, Yan Sun, Hao Chen, Ye Lu, Yan Wu, Haiying Jiang, Wenting Li, Li Li, Hongguang Zhou, Mianhua Wu
      Journal of Ethnopharmacology.2020; 258: 112836.     CrossRef
    • Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective
      Beatrice Aramini, Valentina Masciale, Khawaja Husnain Haider
      World Journal of Stem Cells.2020; 12(6): 406.     CrossRef
    • Circulating miRNAs in Small Extracellular Vesicles Secreted by a Human Melanoma Xenograft in Mouse Brains
      Loredana Guglielmi, Marta Nardella, Carla Musa, Ingrid Cifola, Manuela Porru, Beatrice Cardinali, Ilaria Iannetti, Chiara Di Pietro, Giulia Bolasco, Valentina Palmieri, Laura Vilardo, Nicolò Panini, Fabrizio Bonaventura, Massimiliano Papi, Ferdinando Scav
      Cancers.2020; 12(6): 1635.     CrossRef
    • Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer
      Zhaoyan Qiu, Ning Liang, Qian Huang, Tao Sun, Hongyuan Xue, Tianyu Xie, Xinxin Wang, Qian Wang
      Frontiers in Oncology.2020;[Epub]     CrossRef
    • Circulating miR-1246 in the Progression of Chronic Obstructive Pulmonary Disease (COPD) in Patients from the BODE Cohort


      Sara Cazorla-Rivero, Glorian Mura-Escorche, Francisca Gonzalvo-Hernández, Delia Mayato, Elizabeth Córdoba-Lanús, Ciro Casanova
      International Journal of Chronic Obstructive Pulmonary Disease.2020; Volume 15: 2727.     CrossRef
    • miR-1260b Activates Wnt Signaling by Targeting Secreted Frizzled-Related Protein 1 to Regulate Taxane Resistance in Lung Adenocarcinoma
      Jin Ren, Deqiang Wang, Hanpeng Huang, Xiaoqin Li, Xiufen Zhuang, Jian Li
      Frontiers in Oncology.2020;[Epub]     CrossRef
    • Exosomes derived from human umbilical cord blood mesenchymal stem cells improve hepatic ischemia reperfusion injury via delivering miR-1246
      Kun Xie, Lei Liu, Jiangming Chen, Fubao Liu
      Cell Cycle.2019; 18(24): 3491.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway
      Cancer Res Treat. 2019;51(4):1420-1429.   Published online March 4, 2019
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    • 2
    • 3
    MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway
    Image Image Image Image
    Fig. 1. Expression profiling of circulating miRNAs in patients with lung cancer. (A) MiRNA assay analysis of circulating miRNAs from the patients with lung cancer was presented in a heat map (11 lung cancer vs. 5 health control; the 11 lung cancer group includes 4 squamous carcinomas, 4 adenocarcinomas, and 2 small cell lung cancer cases). (B) The 14 miRNAs were differentially expressed in 11 lung cancer vs. 5 health control (p < 0.05, fold-change > 2 or < 0.5). A differentially expressed miRNA was considered if their expression levels showed with fold-changes greater than 2.0 or less than 0.5. Red and blue colors indicate increased and decreased expression, respectively.
    Fig. 2. MiR-1246 enhances the migration and invasion of A549 cells. Migration and invasion assays were performed after A549 transfected with miR-1246 mimics or negative control (NC) miRNA, miR-1246 inhibitor or inhibitor negative control (Inh-NC) for 48 hours. The cells that migrated and invasive were counted, the representative images were shown. Scale bar=100 μm. (A) The migration ability of A549 cells. (B) The invasion capacity of A549 cells. Experiments were performed at least in triplicate and data are represented as mean±standard error of mean (*p < 0.05).
    Fig. 3. MiR-1246 promotes epithelial-mesenchymal transition (EMT) in A549 cells. The mRNA expression of markers (E-cadherin, vimentin, and transforming growth factor β [TGF-β]) related to EMT were measured by real-time quantitative polymerase chain reaction (RT-qPCR) assay. A549 cells were transfected with miR-1246 mimics or negative control (NC), miR-1246 inhibitor, or inhibitor negative control (Inh-NC). After 48 hours, whole cell lysates were prepared and RT-qPCR assay determined the mRNA level of EMT-related markers. (A) The mRNA levels of E-cadherin, vimentin, and TGF-β in A549 cells transfected by miR-1246 mimics or NC. (B) The levels of E-cadherin, vimentin, and TGF-β mRNA in A549 cells transfected with miR-1246 inhibitor or Inh-NC. All experiments were carried out more than three times and results are expressed as mean±standard error of mean (*p < 0.05, **p < 0.01).
    Fig. 4. MiR-1246 regulates Wnt/β-catenin signaling pathway through targeting glycogen synthase kinase-3β (GSK-3β)/β-catenin. (A) GSK-3β was identified as a putative target of miR-1246 through prediction databases for bioinformatics search. Schematics showing the predicted binding site of miR-1246 in the 3' untranslated region of GSK-3β. (B-E) The protein levels of GSK-3β (B, D, E) and β-catenin (C, D, E) from A549 cells transfected with miR-1246 mimics or negative control (NC), miR-1246 inhibitor, or inhibitor negative control (Inh-NC) were determined by immunofluorescence and western blot assay, respectively. All the values are shown as mean±standard error of mean and pooled from three independent experiments (*p < 0.05).
    MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway
    Pathway Gene (%) p-value lg(p-value)
    CDC42 signaling events 13.547 0.007 2.145
    TGF-β receptor signaling 5.843 0.009 2.029
    TNF receptor signaling pathway 5.688 0.013 1.889
    p53 pathway 3.619 0.036 1.447
    Epithelial-to-mesenchymal transition 3.464 0.061 1.212
    Canonical Wnt signaling pathway 3.309 0.003 2.503
    C-Myc pathway 2.947 0.029 1.537
    Regulation of nuclear β-catenin signaling 2.689 0.032 1.501
    Table 1. The enriched FunRich pathway of predicted genes

    TGF-β, transforming growth factor β; TNF, tumor necrosis factor.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP